EGFR and neoplasm: Novel results from our systems-level molecular profiling analysis include linking lineage (reflected by MITF expression), BRAF zygosity, cell-line specific mutations in proto-oncogenes and tumor suppressors and widespread transcriptional upregulation of ErbB family members and other receptor tyrosine kinases in the response and resistance of melanoma cells to PLX4720.